S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature

NeurAxis (NRXS) Competitors

$3.40
-0.09 (-2.58%)
(As of 03/1/2024 ET)

NRXS vs. NDRA, MOVE, POCI, ECOR, PXDT, MBTC, VANI, HYPR, CNTX, and SSKN

Should you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include ENDRA Life Sciences (NDRA), Movano (MOVE), Precision Optics (POCI), electroCore (ECOR), Pixie Dust Technologies (PXDT), Nocturne Acquisition (MBTC), Vivani Medical (VANI), Hyperfine (HYPR), Context Therapeutics (CNTX), and STRATA Skin Sciences (SSKN). These companies are all part of the "medical" sector.

NeurAxis vs.

NeurAxis (NASDAQ:NRXS) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, community ranking, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

ENDRA Life Sciences has a consensus target price of $9.00, suggesting a potential upside of 696.46%. Given ENDRA Life Sciences' higher probable upside, analysts plainly believe ENDRA Life Sciences is more favorable than NeurAxis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ENDRA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

6.0% of ENDRA Life Sciences shares are owned by institutional investors. 4.8% of ENDRA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

NeurAxis' return on equity of 0.00% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxisN/A N/A N/A
ENDRA Life Sciences N/A -211.26%-151.72%

ENDRA Life Sciences received 234 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 62.67% of users gave ENDRA Life Sciences an outperform vote.

CompanyUnderperformOutperform
NeurAxisOutperform Votes
1
100.00%
Underperform Votes
No Votes
ENDRA Life SciencesOutperform Votes
235
62.67%
Underperform Votes
140
37.33%

In the previous week, ENDRA Life Sciences had 3 more articles in the media than NeurAxis. MarketBeat recorded 5 mentions for ENDRA Life Sciences and 2 mentions for NeurAxis. ENDRA Life Sciences' average media sentiment score of 0.53 beat NeurAxis' score of 0.00 indicating that ENDRA Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeurAxis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ENDRA Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

NeurAxis has higher revenue and earnings than ENDRA Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$2.68M6.71-$4.78MN/AN/A
ENDRA Life SciencesN/AN/A-$13.18M-$2.80-0.40

Summary

ENDRA Life Sciences beats NeurAxis on 6 of the 11 factors compared between the two stocks.


Get NeurAxis News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXS vs. The Competition

MetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$17.99M$3.17B$5.19B$7.63B
Dividend YieldN/A1.71%2.82%3.87%
P/E RatioN/A12.39199.0614.81
Price / Sales6.7171.113,036.0080.43
Price / CashN/A49.3698.8355.35
Price / BookN/A4.364.524.54
Net Income-$4.78M$88.40M$114.88M$211.55M
7 Day Performance-2.58%3.88%5.69%3.36%
1 Month Performance39.92%5.17%11.23%6.68%
1 Year PerformanceN/A40.77%14.03%8.85%

NeurAxis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NDRA
ENDRA Life Sciences
1.8209 of 5 stars
$1.15
flat
$9.00
+682.6%
-69.9%$12.70MN/A-0.4121Short Interest ↑
High Trading Volume
MOVE
Movano
0 of 5 stars
$0.59
flat
N/A-55.5%$32.64MN/A-0.7634Short Interest ↑
High Trading Volume
POCI
Precision Optics
0 of 5 stars
$5.88
+1.9%
N/A-23.6%$35.67M$21.05M-19.5984
ECOR
electroCore
2.5887 of 5 stars
$6.88
-0.7%
$10.00
+45.3%
+115.7%$41.28M$8.59M-1.6562
PXDT
Pixie Dust Technologies
0 of 5 stars
$3.04
-5.9%
N/AN/A$44.69M$5.18M0.0078Short Interest ↑
MBTC
Nocturne Acquisition
0 of 5 stars
$10.50
-4.5%
N/A-2.6%$54.50MN/A0.002Upcoming Earnings
Short Interest ↑
VANI
Vivani Medical
1.0283 of 5 stars
$1.07
-1.8%
N/A+178.4%$54.60MN/A-1.9150News Coverage
Gap Down
HYPR
Hyperfine
2.0632 of 5 stars
$1.03
flat
$2.38
+130.6%
-25.5%$73.75M$6.81M-1.56136
CNTX
Context Therapeutics
3.0699 of 5 stars
$1.16
-0.9%
$4.50
+287.9%
+51.1%$18.53MN/A-0.899Gap Down
SSKN
STRATA Skin Sciences
1.9021 of 5 stars
$0.52
+2.0%
$3.80
+627.8%
-55.4%$18.30M$36.16M-2.61114News Coverage
Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:NRXS) was last updated on 3/2/2024 by MarketBeat.com Staff